Multiple receptor signals modulate protein degradation in C. elegans muscle through multiple mechanisms. Activation of EGL-15 FGF receptor promotes activation of MPK-1 MAP kinase, which in turn triggers non-proteasome dependent protein degradation (Szewczyk & Jacobson, 2003). This is opposed by signal from the DAF-2 insulin/IGF receptor (Szewczyk & Jacobson, 2007). In a seemingly independent mechanism, influx of calcium upon activation of nicotinic acetylcholine receptor inhibits proteasome-mediated muscle protein degradation (Szewczyk et al., 2000). We have now found that UNC-43 calcium/calmodulin-dependent protein kinase II (CaMKII) also has a role in controlling muscle protein degradation. Gain-of-function mutation
unc-43(
n498) activates CaMKII (without increasing its phosphorylation) and promotes progressive protein degradation. The CaMKII-gf mutation causes an increase in phospho-MAPK, whereas transgene-activated MAPK does not increase phospho-CaMKII. A mutant (
egl-19gf) with elevated intramuscular calcium also contains increased levels of both phospho-CaMKII and phospho-MAPK, suggesting that elevated calcium activates CaMKII, which in turn activates MAPK by an unknown mechanism. Conversely, we find that reduction-of-function mutant
unc-43(
e408) is resistant to protein degradation that occurs in wild-type after either hyperactivation of the FGFR pathway or inhibition of the IGFR pathway. The amount of total MPK-1 protein is increased in
unc-43rf mutants, possibly implying that the worm attempts to compensate for low CaMKII signal by up-regulating MAPK. Our current hypothesis is that UNC-43 CaMKII acts as a calcium-responsive positive modulator (sensitivity control?) of the FGFR-Ras-Raf-MEK-MAPK cascade. Reduction-of-function mutations in either
tax-6 or
cnb-1, which encode the two subunits of the calcium/calmodulin-dependent protein phosphatase calcineurin, result in decreased protein levels in muscle, suggesting that calcineurin may act to oppose muscle protein degradation. Neither reduction- nor gain-of-function mutations in
tax-6 or
cnb-1 alter the levels of total or phospho-CaMKII; thus, calcineurin may act downstream of or in parallel to CaMKII to provide yet another mechanism by which calcium regulates muscle protein degradation. Supported by NSF grant MCB-0542355.